News | Mammography | February 11, 2019

Mount Sinai's Digital 3-D Mammography Van Rolls Into New York City

Program designed to break down barriers to breast cancer screening

Mount Sinai's Digital 3-D Mammography Van Rolls Into New York City

February 11, 2019 — Mount Sinai Hospital recently launched the Mount Sinai Mobile Mammography Program (MMP), bringing essential breast cancer detection services and education to women in New York City. It is the only van equipped with digital breast tomosynthesis – high-quality, state-of-the-art, digital 3D mammography technology — serving women in all five boroughs.

Digital breast tomosynthesis (DBT) produces images of breast tissue in 1-millimeter-thin layers, and allows radiologists to better detect breast tissue abnormalities. The Mount Sinai van also is equipped with an information system that incorporates a breast cancer risk assessment tool, and makes intake and follow-up communications available in English, Spanish, Chinese, Russian, French and Haitian Creole.

According to Laurie Margolies, M.D., system chief of breast imaging, Mount Sinai Health System and professor of radiology, Icahn School of Medicine at Mount Sinai: “Annual screening mammography beginning at age 40 has been shown to save lives. Our goal is to help women understand the benefits of mammographic screening and early detection. We want to break down as many barriers as possible, and encourage women to participate in screening mammography. By reaching women right in their communities, Mount Sinai’s Mobile Mammography Program helps reduce disparities in breast cancer detection and survival in those disproportionately burdened by this disease.”

One out of four women age 40 and older in New York City is not regularly screened for breast cancer. (1) Breast cancer is the most common cancer in women, except for skin cancers, and the second leading cause of cancer-related deaths among women. (2) New York State has one of the highest breast cancer incidence rates in the country (3) and in New York City alone, there are approximately 6,000 new cases of breast cancer each year, and more than 1,000 breast cancer-related deaths. (4)

Minority women face significant disparities in breast cancer screening and outcomes. Nationally, less than 50 percent of all Asian, Latina and Native American women aged 40 and older had a mammogram within the past year. (5) While black women have the highest screening rate among minority women at 55 percent, they also have the highest breast cancer mortality. (5)

Minority women face interwoven cultural, language, social and economic barriers that prevent them from obtaining mammograms regularly, which leads to poorer breast cancer-related outcomes. Commonly documented barriers include lack of health insurance, limited English proficiency, fatalistic beliefs about breast cancer and lack of breast cancer screening knowledge.(6, 7)

To address these issues, the Mobile Mammography Program provides culturally targeted educational workshops discussing the importance of mammography screenings. These are offered in multiple languages including English, Spanish, French, Mandarin and Cantonese. Mount Sinai also offers workshops tailored to the Muslim and LGBTQ communities.

Multilingual patient navigators with access to language interpreters are available to assist participants make screening appointments and access follow-up services.

The program is made possible with funds from Health Research Inc. (HRI) and the State of New York.

“By bringing screening mammography to New Yorkers via this mobile unit and using culturally-based education, we will help save lives,” said Margolies. “This is our overarching goal. Yearly screening mammography reduces, as much as possible, a woman’s risk of dying from breast cancer. Mount Sinai’s new ‘care on wheels’ will make it much easier for many New Yorkers to be screened. We are humbled and honored to play a role in improving women’s health, and to be welcomed by so many community organizations that are hosting Mount Sinai screening and education events.”

For more information: www.mountsinai.org

References

  1. New York City Department of Health and Mental Hygiene. Breast cancer screening (mammography), 2014 (Age adjusted). https://a816-healthpsi.nyc.gov/epiquery/sasresults.jsp
  2. New York State Department of Health. Cancer incidence and mortality for New York City, 2011-2015. https://www.health.ny.gov/statistics/cancer/registry/vol1/v1rnyc.htm
  3. Centers for Disease Control and Prevention. United State Cancer Statistics Data Visualizations. Female Breast, All Ages, All Races/Ethnicities, Female Rate per 100,000 Women. https://gis.cdc.gov/Cancer/USCS/DataViz.html
  4. New York State Department of Health. Female breast cancer incidence and mortality by year, New York City, 1975-2015. https://www.health.ny.gov/statistics/cancer/registry/table2/tb2breastnyc.htm
  5. American Cancer Society. Breast cancer facts & figures 2017-2018. Atlanta, GA: American Cancer Society; 2017. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/breast-cancer-facts-and-figures/breast-cancer-facts-and-figures-2017-2018.pdf
  6. Gray TF, Cudjoe J, Murphy J, Thorpe JW, Wenzel J, Han H. Disparities in cancer screening practices among minority and underrepresented populations. Seminars in Oncology Nursing. 2017;33(2):184-198.
  7. Moy B, Park ER, Feibelmann S, Chiang S, Weissman JS. Barriers to repeat mammography: cultural perspectives of African‐American, Asian, and Hispanic women. Psycho-oncology. 2005;15(7):623-634.

Related Content

Imago Systems Announces Collaboration With Mayo Clinic for Breast Imaging

Image courtesy of Imago Systems

News | Mammography | August 14, 2019
Image visualization company Imago Systems announced it has signed a know-how license with Mayo Clinic. The multi-year...
Artificial Intelligence Could Yield More Accurate Breast Cancer Diagnoses
News | Artificial Intelligence | August 13, 2019
University of California Los Angeles (UCLA) researchers have developed an artificial intelligence (AI) system that...
Lake Medical Imaging Selects Infinitt for Multi-site RIS/PACS
News | PACS | August 09, 2019
Infinitt North America will be implementing Infinitt RIS (radiology information system)/PACS (picture archiving and...
Volpara to Distribute Screenpoint Medical's Transpara AI Solution
News | Breast Imaging | August 02, 2019
Volpara Solutions and ScreenPoint Medical BV signed an agreement under which Volpara will sell ScreenPoint's Transpara...
Ikonopedia Releases Automated Combined Reporting Package at AHRA
News | Mammography Reporting Software | July 26, 2019
Ikonopedia showcased its recently released Automated Combined Reporting package and its entire suite of structured...
Hologic Partners With MagView to Develop Unifi EQUIP Solution
Technology | Mammography Reporting Software | July 25, 2019
Hologic announced a partnership with mammography information solutions provider MagView to develop Unifi EQUIP, an...
Fujifilm Releases Tomosynthesis Biopsy Option for Aspire Cristalle Mammography System
Technology | Breast Biopsy Systems | July 24, 2019
Fujifilm Medical Systems U.S.A. Inc. recently expanded its breast imaging solutions with the launch of its...
IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017.

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017, and who had health records for at least one year prior to the mammogram. The algorithm was trained on 9,611 mammograms. Image courtesy of Radiology.

Feature | Artificial Intelligence | July 19, 2019 | Michal Chorev
Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer...
Paragon Biosciences Launches Qlarity Imaging to Advance FDA-cleared AI Breast Cancer Diagnosis System

Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire.

Technology | Artificial Intelligence | July 18, 2019
Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded...
FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).